| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |